QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wedbush-maintains-outperform-on-sana-biotechnology-raises-price-target-to-6

Wedbush analyst Martin Fan maintains Sana Biotechnology (NASDAQ:SANA) with a Outperform and raises the price target from $5...

 hc-wainwright--co-maintains-buy-on-sana-biotechnology-lowers-price-target-to-9

HC Wainwright & Co. analyst Emily Bodnar maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price targ...

 sana-biotechnology-q3-adj-eps-015-beats-018-estimate

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(...

 citizens-maintains-market-outperform-on-sana-biotechnology-raises-price-target-to-8

Citizens analyst Reni J. Benjamin maintains Sana Biotechnology (NASDAQ:SANA) with a Market Outperform and raises the price t...

 sana-biotech-stock--the-next-100-bagger

Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."

 wedbush-initiates-coverage-on-sana-biotechnology-with-outperform-rating-announces-price-target-of-5

Wedbush analyst Martin Fan initiates coverage on Sana Biotechnology (NASDAQ:SANA) with a Outperform rating and announces Pr...

 sana-biotechnology-q2-adj-eps-016-beats-021-estimate

Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(...

 update-sana-biotechnology-launches-75m-public-offering-of-common-stock-and-pre-funded-warrants

Sana Biotechnology, Inc. (NASDAQ:SANA) ("Sana"), a company focused on changing the possible for patients through engine...

 sana-biotechnology-study-published-in-nejm-shows-hip-modified-islet-cells-function-without-immunosuppression-in-type-1-diabetes-patient

Data Demonstrate that Sana's Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Pers...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION